Partner
Lou Lange
Partner, Asset Management Ventures
- Firm
- Asset Management Ventures
- Title
- Partner
- Role
- Partner
- Known as
- Investor
Claim, correct or request removal
Record updated 17 September 2026
About
Dr. Lange has 22 years experience in academic medicine at Harvard and Washington University, where he served as Chief of Cardiology and Professor of Medicine at Jewish Hospital from 1985-1992 and was one of the first academicians in molecular cardiology. He founded CV Therapeutics based on this broad field and as Chairman, CEO and Chief Scientific Officer, led the IPO in 1996 and the overall pipeline development and the initiatives for US FDA and European EMEA approval for Ranexa®, a first-in-class late sodium channel blocker and the first anti-anginal drug class approved in 30 years in the US.
Background
- Education
- Dr. Lange has a Bachelor’s degree from the University of Rochester, an M.D. from Harvard University and a Ph.D. in Biological Chemistry, also from Harvard University.Source (opens in a new tab)
Is this you? Remove my profile
Loading relationship preview